This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4cl1
From Proteopedia
(Difference between revisions)
m (Protected "4cl1" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4cl1 is ON HOLD | + | The entry 4cl1 is ON HOLD until Paper Publication |
Authors: Lambert, S.M., Langley, D.R., Garnett, J.A., Angell, R., Hedgethorne, K., Meanwell, N.A., Matthews, S.J. | Authors: Lambert, S.M., Langley, D.R., Garnett, J.A., Angell, R., Hedgethorne, K., Meanwell, N.A., Matthews, S.J. | ||
Description: The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors | Description: The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors | ||
Revision as of 06:44, 29 January 2014
Unreleased structure
The entry 4cl1 is ON HOLD until Paper Publication
Authors: Lambert, S.M., Langley, D.R., Garnett, J.A., Angell, R., Hedgethorne, K., Meanwell, N.A., Matthews, S.J.
Description: The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors
